Royce & Associates’s ARS Pharmaceuticals SPRY Stock Holding History

Royce & Associates’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$4.47M	Sell
2025 Q1	$8.09M	Sell
2024 Q4	$9.81M	Buy
2024 Q3	$10M	Buy
2024 Q2	$5.49M	Buy
2024 Q1	$5.71M	Buy
2023 Q4	$2.6M	Buy
2023 Q3	$1.75M	Hold
2023 Q2	$3.11M	Buy
2023 Q1	$1.98M	Buy